JCAD, in partnership with Boehringer Ingelheim and the National Psoriasis Foundation (NPF), is excited to bring this special message to our subscribers in preparation for next week’s inaugural GPP Awareness Day.

Tina Bhutani, MD: Raising Awareness for Generalized Pustular Psoriasis

July 30, 2025

Dr. Tina Bhutani highlights the National Psoriasis Foundation’s efforts to raise awareness for generalized pustular psoriasis and support affected patients.

Topics Covered:

GPP awareness initiatives by the NPF
Role of advocacy in rare dermatologic conditions
Importance of education for clinicians and patients
Dr. Bhutani’s role as JCAD Psoriasis Section Editor

Explore Related Resources:

Mitigating Low-Grade Inflammatory Activity in Generalized Pustular Psoriasis

Reviewing the Pathogenesis of Generalized Pustular Psoriasis

MORE GENERALIZED PUSTULAR PSORIASIS VIDEOS

James Song, MD, FAAD: Assessing Systemic GPP Treatment With Targeted Therapy

James Song, MD, FAAD, discusses the severity of generalized pustular psoriasis for patients and options for treatment.

Scott Worswick, MD: Dosing Strategies for Treating Generalized Pustular Psoriasis

Scott Worswick, MD, discusses dosing options for patients with GPP during the treatment of acute flares and maintenance therapy.

Raj Chovatiya, MD, PhD: Advancements in the Management Paradigm for Generalized Pustular Psoriasis

Dr. Chovatiya discusses evolving treatment strategies for Generalized Pustular Psoriasis (GPP) and how recent clinical research is reshaping the management paradigm for this severe inflammatory

Johann E. Gudjonsson, MD, PhD: Mitigating Low-grade Inflammatory Activity in Generalized Pustular Psoriasis

Dr. Johann Gudjonsson discusses how spesolimab may reduce low-grade inflammation between flares in patients with generalized pustular psoriasis (GPP). Topics Covered: Subclinical inflammation in GPP

Tina Bhutani, MD: Reviewing the Pathogenesis of Generalized Pustular Psoriasis

Dr. Bhutani reviews the underlying disease mechanisms of Generalized Pustular Psoriasis (GPP), focusing on the role of inflammatory signaling pathways that drive the condition. Her

Tina Bhutani, MD: Assessing the Quality of Life Impact in Patients with Generalized Pustular Psoriasis

Dr. Bhutani examines the significant quality-of-life burden associated with Generalized Pustular Psoriasis (GPP), a rare and severe inflammatory skin condition. Her discussion highlights how frequent

Tina Bhutani, MD: Diagnosing Patients with Generalized Pustular Psoriasis

Dr. Bhutani discusses the diagnostic challenges associated with Generalized Pustular Psoriasis (GPP), a rare and often unpredictable inflammatory skin disease. Her presentation highlights the importance

JCAD Archives